TechNavio's analysts forecast the Global Vascular Stents Market to grow at a CAGR of 8.21 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increasing prevalence of cardiovascular disease. The Global Vascular Stents Market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, availability of alternative therapies could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 16475 2000 USD New
Global Vascular Stents Market 2012-2016
 
 

Global Vascular Stents Market 2012-2016

  • Category : Healthcare
  • Published On : April   2013
  • Pages : 45
  • Publisher : Technavio
 
 
 

TechNavio's analysts forecast the Global Vascular Stents Market to grow at a CAGR of 8.21 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increasing prevalence of cardiovascular disease. The Global Vascular Stents Market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, availability of alternative therapies could pose a challenge to the growth of this market. 

TechNavio's report, the Global Vascular Stents market 2012–2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Vascular Stents market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space Abbott Laboratories, Medtronic Inc., Boston Scientific Corp., and Cordis Corp.

Other vendors mentioned in the report are MicroPort Scientific Corp., Cook Medical, Biosensors International Ltd., and B. Braun Melsungen AG, Allvivo Vascular Inc., Arterial Remodeling Technologies, Biocompatibles Ltd., Biotronik KG, Blue Medical, Cook Medical Inc., Devax Inc., Endovasc Inc., Goodman Co. Ltd., InnoCore Technologies BV, MIV Therapeutics Inc., Reva Medical Inc., Stentys SA, SurModics Inc., Translumina GmbH, X-Cell Medical Inc. and Xtent Inc.

Key questions answered in this report:

What will the market size be in 2016 and at what will be the growth rate?

What are key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by key vendors?

What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.



 


1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Scope of the Report


Market Overview

Product Offerings

5. Market Landscape

5.1. Market Size and Forecast 

5.2. Market Segmentation by Category

5.3. Market Segmentation by Delivery Platform

5.4. Global Coronary Stents Market

Market Size and Forecast

Geographical Segmentation

Market Segmentation

5.5. Global Drug Eluting Stents Market

Market Size and Forecast

5.6. Global Bare Metal  Stents Market

Market Size and Forecast

5.7. Global Peripheral Vascular Stents Market

Market Size and Forecast

5.8. Global Carotid Artery Stents Market

Market Size and Forecast

5.9. Five Forces Analysis

6. Geographical Segmentation

7. Key Leading Countries

8. Vendor Landscape

9. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis


15.1. Abbott Laboratories

15.1.1. Business Overview

15.1.2. Key Information

15.1.3. SWOT Analysis

15.2. Medtronic Inc.

15.2.1. Business Overview

15.2.2. Business Segmentation

15.2.3. Key Information

15.2.4. SWOT Analysis

15.3. Boston Scientific Corp.

15.3.1. Business Overview

15.3.2. Key Information

15.3.3. SWOT Analysis

15.4. Cordis Corp.

15.4.1. Business Overview

15.4.2. Business Segmentation

15.4.3. Key Information

15.4.4. SWOT Analysis

16. Other Reports in this Series



List of Exhibits:

Exhibit 1:  Global Vascular Stents Market 2012–2016 (US$ billion)

Exhibit 2:  Global Vascular Stents Market by Category Segmentation

Exhibit 3:  Global Vascular Stents Market by Category Segmentation 2012

Exhibit 4:  Global Vascular Stents Market Segmentation by Delivery Platform

Exhibit 5:  Global Coronary Stents Market 2012-2016 (US$ billion)

Exhibit 6:  Global Coronary Stents Market by Geographical Segmentation2012

Exhibit 7:  Global Coronary Stents Market Segmentation 

Exhibit 8:  Global Coronary Stents Market by Product Segmentation 2012

Exhibit 9:  Global Coronary Stents Market by Product Segmentation 2016

Exhibit 10:  Global Drug Eluting Stents Market 2012-2016 (US$ billion)

Exhibit 11:  Global Bare Metal Stents Market 2012-2016 (US$ billion)

Exhibit 12:  Global Peripheral Vascular Stents Market 2012-2016 (US$ billion)

Exhibit 13:  Global Carotid Artery Stents Market 2012-2016 (US$ billion)

Exhibit 14:  Global Vascular Stents Market by Geographical Segmentation 2012

Exhibit 15:  Global Vascular Stents Market by Vendor Segmentation 2012

Exhibit 16:  Business Segmentation of Abbott Laboratories

Exhibit 17:  Business Segmentation of Medtronic Inc.

Exhibit 18:  Business Segmentation of Boston Scientific Corp.

Exhibit 19:  Business Segmentation of Cordis Corp.



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT